These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 21489808)

  • 1. Error prediction of LiF-TLD used for gamma dose measurement for BNCT.
    Liu HM; Liu YH
    Appl Radiat Isot; 2011 Dec; 69(12):1846-9. PubMed ID: 21489808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma dose measurement in a water phantom irradiated with the BNCT facility at THOR.
    Liu HM; Hsu PC; Liaw TF
    Radiat Prot Dosimetry; 2001; 95(4):353-8. PubMed ID: 11707034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and characteristics of the HANARO neutron irradiation facility for applications in the boron neutron capture therapy field.
    Kim MS; Lee BC; Hwang SY; Kim H; Jun BJ
    Phys Med Biol; 2007 May; 52(9):2553-66. PubMed ID: 17440252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of dose rate scaling factors used in NCTPlan treatment planning code for the BNCT beam of THOR.
    Hsu FY; Liu MT; Tung CJ; Hsueh Liu YW; Chang CC; Liu HM; Chou FI
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S130-3. PubMed ID: 19375926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of gamma-ray dose and neutron activation in BNCT beams using TLD-200.
    Tsai WC; Yang ZY; Lee SC; Jiang SH
    Appl Radiat Isot; 2020 Aug; 162():109146. PubMed ID: 32310088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of different TL detectors for the photon dosimetry in mixed radiation fields used for BNCT.
    Burgkhardt B; Bilski P; Budzanowski M; Böttger R; Eberhardt K; Hampel G; Olko P; Straubing A
    Radiat Prot Dosimetry; 2006; 120(1-4):83-6. PubMed ID: 16644976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microdosimetry study of THOR BNCT beam using tissue equivalent proportional counter.
    Hsu FY; Hsiao HW; Tung CJ; Liu HM; Chou FI
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S175-8. PubMed ID: 19447042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of the new THOR epithermal neutron beam for BNCT.
    Tung CJ; Wang YL; Hsu FY; Chang SL; Liu YW
    Appl Radiat Isot; 2004 Nov; 61(5):861-4. PubMed ID: 15308158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-rate scaling factor estimation of THOR BNCT test beam.
    Hsu FY; Tung CJ; Chen JC; Wang YL; Huang HC; Zamenhof RG
    Appl Radiat Isot; 2004 Nov; 61(5):881-5. PubMed ID: 15308162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QA measurement of gamma-ray dose and neutron activation using TLD-400 for BNCT beam.
    Tsai WC; Huang CK; Jiang SH
    Appl Radiat Isot; 2018 Jul; 137():73-79. PubMed ID: 29587162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutron spectra measurement and comparison of the HFR and THOR BNCT beams.
    Liu YH; Nievaart S; Tsai PE; Liu HM; Moss R; Jiang SH
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S137-40. PubMed ID: 19409798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new approach to dose estimation and in-phantom figure of merit measurement in BNCT by using artificial neural networks.
    Ahangari R; Afarideh H
    Australas Phys Eng Sci Med; 2011 Dec; 34(4):467-79. PubMed ID: 22042720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose calculation in biological samples in a mixed neutron-gamma field at the TRIGA reactor of the University of Mainz.
    Schmitz T; Blaickner M; Schütz C; Wiehl N; Kratz JV; Bassler N; Holzscheiter MH; Palmans H; Sharpe P; Otto G; Hampel G
    Acta Oncol; 2010 Oct; 49(7):1165-9. PubMed ID: 20831509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation shielding evaluation of the BNCT treatment room at THOR: a TORT-coupled MCNP Monte Carlo simulation study.
    Chen AY; Liu YW; Sheu RJ
    Appl Radiat Isot; 2008 Jan; 66(1):28-38. PubMed ID: 17825572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calculation of dose components in head phantom for boron neutron capture therapy.
    da Silva AX; Crispim VR
    Cell Mol Biol (Noisy-le-grand); 2002 Nov; 48(7):813-7. PubMed ID: 12622057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose determination using alanine detectors in a mixed neutron and gamma field for boron neutron capture therapy of liver malignancies.
    Schmitz T; Blaickner M; Ziegner M; Bassler N; Grunewald C; Kratz JV; Schütz C; Langguth P; Sharpe P; Palmans H; Holzscheiter MH; Otto G; Hampel G
    Acta Oncol; 2011 Aug; 50(6):817-22. PubMed ID: 21767179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials for treating recurrent head and neck cancer with boron neutron capture therapy using the Tsing-Hua Open Pool Reactor.
    Wang LW; Liu YH; Chou FI; Jiang SH
    Cancer Commun (Lond); 2018 Jun; 38(1):37. PubMed ID: 29914577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose homogeneity in boron neutron capture therapy using an epithermal neutron beam.
    Konijnenberg MW; Dewit LG; Mijnheer BJ; Raaijmakers CP; Watkins PR
    Radiat Res; 1995 Jun; 142(3):327-39. PubMed ID: 7761583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resumption of JRR-4 and characteristics of neutron beam for BNCT.
    Nakamura T; Horiguchi H; Kishi T; Motohashi J; Sasajima F; Kumada H
    Appl Radiat Isot; 2011 Dec; 69(12):1932-5. PubMed ID: 21621416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of a method based on TLD detectors for in-phantom dosimetry in BNCT.
    Gambarini G; Klamert V; Agosteo S; Birattari C; Gay S; Rosi G; Scolari L
    Radiat Prot Dosimetry; 2004; 110(1-4):631-6. PubMed ID: 15353721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.